GYRE   $7.39  2.07% Market Closed After Close 7.39 0.0

Gyre Therapeutics, Inc.
Total Cash 25.10M
totalCashPerShare 0.293
EBITDA 20.08M
Total Debt 1.96M
quickRatio 2.871
currentRatio 3.436
Total Revenue 111.59M
debtToEquity 2.095
Revenue/Share 1.464
ROA 0.10181
ROE -0.82741
grossProfits
freeCashflow 8.44M
operatingCashflow 8.33M
earningsGrowth -0.70
revenueGrowth -0.14
grossMargins 0.96251
ebitdaMargins 0.17996
operatingMargins 0.12932
profitMargins -0.77042997
enterpriseValue 1.25B
forwardPE 31.456522
floatShares 15.82M
sharesOutstanding 93.42M
sharesShort 448.70K
sharesShortPriorMonth 308.40K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.75%
heldPercentInstitutions 0.01%
Short Ratio help_outline 7.60%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.706
Price To Book help_outline 20.50
earningsQuarterlyGrowth 0.90
netIncomeToCommon -85.97M
trailingEps -1.01%
forwardEps 0.46%
enterpriseToEbitda 62.18
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 56
lastUpdated Nov. 2, 2024, 6:41 a.m.